FINHUB Insights

DVA · Q1 FY26 · Mar 31, 2026

DaVita Q1 FY26: where the revenue came from and where it went

DaVita Q1 FY26: revenue $3.4B (+6% year over year). Net profit $0.2B. Largest cohort U.S.Dialysis and Related Lab $2.9B. The whole income statement as a sankey diagram from the SEC filing.

Period
Mar 31, 2026
Reported
May 5, 2026 10-Q
Sankey diagram of DaVita's income statement for Q1 FY26: revenue of $3.4 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.4B +6% year over year
Gross profit$1.1B 32% margin
Operating profit$0.5B 14% margin
Net profit$0.2B 6% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
ItemValueShare of revenueYear over year
Revenue 3.4 100% +6%
U.S.Dialysis and Related Lab 2.9 85% +4%
All Other Segments 0.5 15% +20%
Cost of revenue−2.368%
Gross profit1.132% margin+1pp
G&A−0.412%+1pp
Other−0.25%+0pp
Operating profit0.514% margin+0pp
Tax−0.1
Interest & other costs−0.2
Net profit0.26%+1pp
Filing on EDGAR More quarters of DVA

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters